Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Multifunctional Roles of Natural Aaptodine in Alzheimer's Disease: Insights from DFT and MD Studies
Thi Chinh Ngo1,2, Hoang Linh Nguyen2,3, Dinh Hieu Truong1,2
1Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam.
Abstract:
The multifunctional properties of aaptodine A in preventing oxidative stress and inhibiting amyloid-beta (Aβ) aggregation, both of which are considered the main causes of Alzheimer's disease (AD), are the focus of this study. Using the M06-2X and M06 density functional theory (DFT) methods, the study examines the scavenging of HO· and HOO· radicals, as well as the reactions involving Fe3+/Cu2+ chelation. Docking and molecular dynamics (MD) simulations further assess the inhibitory effect of aaptodine A on Aβ aggregation. The findings indicate that aaptodine A exhibits a strong ability to scavenge the HO· radical (rate constant k = 1.69 × 1010 M-1 s-1); however, it is ineffective against the HOO· radical. Furthermore, aaptodine A demonstrates significant chelating activity with Cu2+, particularly showing effective scavenging ability for both Cu2+ and Fe3+ ions when the complex formation occurs with two ligands. These bioactivities help suppress the formation of reactive free radicals, often associated with metal ions, and mitigate Cu2+-induced neurotoxicity linked to Aβ in AD. Additionally, analyses using MM/PBSA and the accelerated weight histogram (AWH) methods reveal that aaptodine A exhibits a strong binding affinity to Aβ42 fibril structures. Its binding affinities are comparable to those of curcumin, a well-known compound recognized for its ability to inhibit the formation of Aβ fibrils and oligomers. The AWH results with tetramer indicate that aaptodine A binds to both toxic oligomeric species and the mature fibril. As a result, aaptodine A exhibits potential antioxidant activity through a secondary mechanism and may serve as a promising candidate for inhibiting toxic Aβ aggregates associated with AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

